Murphy DL, Lebin JA, Severtson SG, Olsen HA, Dasgupta N, Dart RC. Comparative rates of mortality and serious adverse effects among commonly prescribed opioid analgesics. Drug Saf 2018;41(8):787–95. https://www.ncbi.nlm.nih.gov/pubmed/29582394
Owsiany MT, Hawley CE, Triantafylidis LK, Paik JM. Opioid management in older adults with chronic kidney disease: a review. Am J Med 2019;132(12):1386–93. https://www.ncbi.nlm.nih.gov/pubmed/31295441
Pergolizzi JV, LeQuang JA, Taylor R, Ossipov MH, Colucci D, Raffa RB. Designing safer analgesics: a focus on mu-opioid receptor pathways. Expert Opin Drug Discov 2018;13(10):965–72. https://www.ncbi.nlm.nih.gov/pubmed/30175624
Richards S, Torre L, Lawther B. Buprenorphine-related complications in elderly hospitalised patients: a case series. Anaesth Intensive Care 2017;45(2):256–61. https://www.ncbi.nlm.nih.gov/pubmed/28267949
Schug SA, Palmer GM, Scott DA, Halliwell R, Trinca J, APM:SE Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine, editors. Acute pain management: scientific evidence. 4th Melbourne: Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine; 2015. https://www.anzca.edu.au/safety-advocacy/advocacy/college-publications
Swart LM, van der Zanden V, Spies PE, de Rooij SE, van Munster BC. The comparative risk of delirium with different opioids: A systematic review. Drugs Aging 2017;34(6):437–43. https://www.ncbi.nlm.nih.gov/pubmed/28405945
Vosburg SK, Severtson SG, Dart RC, Cicero TJ, Kurtz SP, Parrino MW, et al. Assessment of tapentadol API abuse liability with the researched abuse, diversion and addiction-related surveillance system. J Pain 2018;19(4):439–53. https://www.ncbi.nlm.nih.gov/pubmed/29224919
